Description: Taj Pharma India is Top known Manufacturer, Exporter and Supplier of Colistimethate Sodium for Injection IP 0.5MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor. Taj Pharma India is a reputed and trusted manufacturer, exporter, and supplier of Colistimethate Sodium for Injection IP 0.5MIU, operating from Vapi, Gujarat. This life-saving injectable antibiotic is widely used in hospitals to treat critical Gram-negative bacterial infections, including pneumonia and bloodstream infections in ICU patients. Taj Pharma produces Colistimethate Sodium in WHO-GMP certified facilities, ensuring top-tier quality, purity, and sterility. The product is globally recognized and distributed across India, the Middle East, Africa, and LATAM markets, with full regulatory support. Administered intravenously, Colistimethate Sodium is prescribed under the supervision of a healthcare professional. It is especially beneficial in treating drug-resistant infections where other antibiotics fail. Taj Pharma offers PCD pharma franchise opportunities, third-party manufacturing, and bulk export supplies for this formulation. While generally safe, the injection should be used cautiously during pregnancy and in patients with kidney disorders. It is likely safe during breastfeeding. With a reputation built on consistency, affordability, and international compliance, Taj Pharma remains the top choice for Colistimethate Sodium Injection manufacturing in India. Taj Pharma India is well recognized Manufacturer, Exporter and Supplier of Colistimethate Sodium for Injection IP 0.5MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP 0.5MIU include Slurred speech, upset stomach, gastrointestinal disturbance, generalized itching, red spots or bumps, increased blood urea nitrogen, increased creatinine level in blood, decreased creatinine clearance, respiratory distress, apnea (absence of breathing), renal toxicity, decreased urinary volume, dizziness, paresthesia (tingling or pricking sensation), vertigo, rash, and fever.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 262 KB
